ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Berlex Laboratories

Include trials that are no longer recruiting patients.

3 studies were found.
1.RecruitingCampath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
Condition: Chronic Lymphocytic Leukemia
2.RecruitingFludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
3.RecruitingSpheramine® in advanced Parkinson’s disease (The STEPS Trial)
Condition: Parkinson Disease

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act